Sobanski, Thais
Suraweera, Amila
Burgess, Joshua T.
Richard, Iain
Cheong, Chee Man
Dave, Keyur
Rose, Maddison
Adams, Mark N.
O’Byrne, Kenneth J.
Richard, Derek J.
Bolderson, Emma
Funding for this research was provided by:
Queensland University of Technology
Advance Queensland
Chenhall Foundation
Article History
Received: 6 February 2023
Accepted: 22 August 2023
First Online: 13 September 2023
Competing interests
: The authors declare competing financial interests; EB, DR and KO are founders of Carpe Vitae Pharmaceuticals. EB, JB, MA, KO, DR are inventors on provisional patent applications filed by Queensland University of Technology. The remaining authors do not have any competing interest.